ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2013
Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.Epidemics · 2019Pooled it
- Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis.Journal of Zhejiang University. Science. BPooled it
- A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Travel medicine and infectious diseasePooled it
- Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review.Travel medicine and infectious diseasePooled it
- Generalizing an outbreak cluster detection method for two groups: an application to rabies.Royal Society open science · 2025Article
- Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling study.The Lancet. Global health · 2023Article
- Post-Covid-19 Rhino-Cerebral Mucormycosis: an Observational Study During the Second Wave.Maedica · 2022Article
- Plant-Based Vaccines in Combat against Coronavirus Diseases.Vaccines · 2022Review
- In vitro Anti SARS-CoV-2 Activity and Docking Analysis ofInfection and drug resistance · 2022Article
- Expeditious COVID-19 similarity measure tool based on consolidated SCA algorithm with mutation and opposition operators.Applied soft computing · 2021Article
- Assessment of risk management and control measures against coronavirus disease.Saudi journal of biological sciences · 2021Article
- Sequence and phylogentic analysis of MERS-CoV in Saudi Arabia, 2012-2019.Virology journal · 2021Article
- Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients: A literature review.Journal of medical virology · 2021Review
- SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.Frontiers in cellular and infection microbiology · 2021Review
- Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics.Translational medicine communications · 2021Review
- Application of Nanotechnology in the COVID-19 Pandemic.International journal of nanomedicine · 2021Review
- A Crowned Killer's Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2.Virologica Sinica · 2020Review
- Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19.Human vaccines & immunotherapeutics · 2020Review
- Genomics functional analysis and drug screening of SARS-CoV-2.Genes & diseases · 2020Article
- Fuzzy clustering method to compare the spread rate of Covid-19 in the high risks countries.Chaos, solitons, and fractals · 2020Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Detection of human cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection internationally is a global public health concern. Rigorous risk assessment is particularly challenging in a context where surveillance may be subject to under-ascertainment and a selection bias towards more severe cases. We would like to assess whether the virus is capable of causing widespread human epidemics, and whether self-sustaining transmission is already under way. Here we review possible transmission scenarios for MERS-CoV and their implications for risk assessment and control. We discuss how existing data, future investigations and analyses may help in reducing uncertainty and refining the public health risk assessment and present analytical approaches that allow robust assessment of epidemiological characteristics, even from partial and biased surveillance data. Finally, we urge that adequate data be collected on future cases to permit rigorous assessment of the transmission characteristics and severity of MERS-CoV, and the public health threat it may pose. Going beyond minimal case reporting, open international collaboration, under the guidance of the World Health Organization and the International Health Regulations, will impact on how this potential epidemic unfolds and prospects for control.
Indexed as
Identifiers
23787162PMC4088931What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.